Characteristics of patients with serotype 5 pneumococcal pneumonia

H. Lawrence (Nottingham, United Kingdom), V. Baskaran (Nottingham, United Kingdom), H. Pick (Nottingham, United Kingdom), P. Daniel (Derby, United Kingdom), C. Rodrigo (Nottingham, United Kingdom), D. Ashton (Nottingham, United Kingdom), R. Edwards-Pritchard (Nottingham, United Kingdom), C. Sheppard (London, United Kingdom), D. Litt (London, United Kingdom), N. Fry (London, United Kingdom), S. Rose (London, United Kingdom), T. Mckeever (Nottingham, United Kingdom), W. Lim (Nottingham, United Kingdom)

Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Session: Clinical challenges in pneumonia
Session type: E-poster session
Number: 2029
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Lawrence (Nottingham, United Kingdom), V. Baskaran (Nottingham, United Kingdom), H. Pick (Nottingham, United Kingdom), P. Daniel (Derby, United Kingdom), C. Rodrigo (Nottingham, United Kingdom), D. Ashton (Nottingham, United Kingdom), R. Edwards-Pritchard (Nottingham, United Kingdom), C. Sheppard (London, United Kingdom), D. Litt (London, United Kingdom), N. Fry (London, United Kingdom), S. Rose (London, United Kingdom), T. Mckeever (Nottingham, United Kingdom), W. Lim (Nottingham, United Kingdom). Characteristics of patients with serotype 5 pneumococcal pneumonia. 2029

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017


Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia
Source: Eur Respir J 2010; 36: 1073-1079
Year: 2010



Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany
Source: Eur Respir J, 59 (2) 2102432; 10.1183/13993003.02432-2021
Year: 2022



Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013




The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012



Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017

A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia
Source: Eur Respir J 2006 Oct 01;28(4):816-823
Year: 2006



Evolution of antimicrobial resistance trends in the last five years in patients with bacteremic Pneumococcal community-acquired pneumonia (CAP-SP)
Source: Eur Respir J 2005; 26: Suppl. 49, 639s
Year: 2005

Clinical effectiveness of pneumococcal vaccination against nonbacteremic pneumonia in people over 50 years
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008


Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Evolution of serotype coverages of 23- and 7-valent pneumococcal vacciness for S. pneumonia isolates from Spanish middle age and older adults with pneumonia, 2002-2007
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008


Absence of leukocytosis in bacteremic pneumococcal pneumonia
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Complicated pneumococcal pneumonia in adults
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

An outbreak of streptococcus pneumonia serotype 1 pneumonia in a UK primary school
Source: Annual Congress 2007 - Paediatric respiratory epidemiology: rare diseases, infectious diseases and asthma
Year: 2007


Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects
Source: Eur Respir J 2005; 26: 1086-1091
Year: 2005



Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia
Source: Eur Respir J 2007; 30: 517-524
Year: 2007



Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia
Source: Eur Respir J 2015; 45: 1632-1641
Year: 2015